144 related articles for article (PubMed ID: 7829400)
41. Effect of fucoidan during activation of human plasminogen.
Doctor VM; Hill C; Jackson GJ
Thromb Res; 1995 Aug; 79(3):237-47. PubMed ID: 8533120
[TBL] [Abstract][Full Text] [Related]
42. Dual Action of NAMI-A in inhibition of solid tumor metastasis: selective targeting of metastatic cells and binding to collagen.
Sava G; Zorzet S; Turrin C; Vita F; Soranzo M; Zabucchi G; Cocchietto M; Bergamo A; DiGiovine S; Pezzoni G; Sartor L; Garbisa S
Clin Cancer Res; 2003 May; 9(5):1898-905. PubMed ID: 12738748
[TBL] [Abstract][Full Text] [Related]
43. Combined chemo/anti-angiogenic cancer therapy against Lewis lung carcinoma (3LL) pulmonary metastases.
Datta A; Kitson RP; Xue Y; al-Atrash G; Mazar AP; Jones TR; Goldfarb RH
In Vivo; 2002; 16(6):451-7. PubMed ID: 12494889
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region in urinary trypsin inhibition.
Kobayashi H; Gotoh J; Kanayama N; Hirashima Y; Terao T; Sugino D
Cancer Res; 1995 May; 55(9):1847-52. PubMed ID: 7728751
[TBL] [Abstract][Full Text] [Related]
45. Fucoidan-Vitamin C complex suppresses tumor invasion through the basement membrane, with scarce injuries to normal or tumor cells, via decreases in oxidative stress and matrix metalloproteinases.
Saitoh Y; Nagai Y; Miwa N
Int J Oncol; 2009 Nov; 35(5):1183-9. PubMed ID: 19787274
[TBL] [Abstract][Full Text] [Related]
46. The effect of fucoidan, heparin and cyanogen bromide-fibrinogen on the activation of human glutamic-plasminogen by tissue plasminogen activator.
Bell J; Duhon S; Doctor VM
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):229-34. PubMed ID: 12695744
[TBL] [Abstract][Full Text] [Related]
47. Effects of epidermal growth factor on invasiveness through the extracellular matrix in high- and low-metastatic clones of RCT sarcoma in vitro.
Yudoh K; Matsui H; Kanamori M; Maeda A; Ohmori K; Tsuji H
Jpn J Cancer Res; 1994 Jan; 85(1):63-71. PubMed ID: 8106290
[TBL] [Abstract][Full Text] [Related]
48. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
Moser TL; Enghild JJ; Pizzo SV; Stack MS
Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
[TBL] [Abstract][Full Text] [Related]
49. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid.
Webber MM; Waghray A
Clin Cancer Res; 1995 Jul; 1(7):755-61. PubMed ID: 9816042
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro.
Saiki I; Murata J; Watanabe K; Fujii H; Abe F; Azuma I
Jpn J Cancer Res; 1989 Sep; 80(9):873-8. PubMed ID: 2513304
[TBL] [Abstract][Full Text] [Related]
51. Inhibitory effects of adhesion oligopeptides on the invasion of squamous carcinoma cells with special reference to implication of alpha v integrins.
Kawahara E; Imai K; Kumagai S; Yamamoto E; Nakanishi I
J Cancer Res Clin Oncol; 1995; 121(3):133-40. PubMed ID: 7536195
[TBL] [Abstract][Full Text] [Related]
52. Analysis of the inhibition of tumour metastasis by sulphated polysaccharides.
Coombe DR; Parish CR; Ramshaw IA; Snowden JM
Int J Cancer; 1987 Jan; 39(1):82-8. PubMed ID: 2878892
[TBL] [Abstract][Full Text] [Related]
53. Protection of transforming growth factor-beta 1 activity by heparin and fucoidan.
McCaffrey TA; Falcone DJ; Vicente D; Du B; Consigli S; Borth W
J Cell Physiol; 1994 Apr; 159(1):51-9. PubMed ID: 7511146
[TBL] [Abstract][Full Text] [Related]
54. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system.
Killeen SD; Wang JH; Andrews EJ; Redmond HP
Br J Cancer; 2009 May; 100(10):1589-602. PubMed ID: 19436306
[TBL] [Abstract][Full Text] [Related]
55. Anticoagulant properties of a fucoïdan fraction.
Colliec S; Fischer AM; Tapon-Bretaudiere J; Boisson C; Durand P; Jozefonvicz J
Thromb Res; 1991 Oct; 64(2):143-54. PubMed ID: 1811335
[TBL] [Abstract][Full Text] [Related]
56. Macrophage colony-stimulating factor mediates invasion of ovarian cancer cells through urokinase.
Chambers SK; Wang Y; Gertz RE; Kacinski BM
Cancer Res; 1995 Apr; 55(7):1578-85. PubMed ID: 7882368
[TBL] [Abstract][Full Text] [Related]
57. Anti-sense RNA of 32-kDa laminin-binding protein inhibits attachment and invasion of a human colon carcinoma cell line.
Mafune K; Ravikumar TS
J Surg Res; 1992 Apr; 52(4):340-6. PubMed ID: 1534386
[TBL] [Abstract][Full Text] [Related]
58. Comparative anticoagulant activity and influence on thrombin generation of dextran derivatives and of a fucoidan fraction.
Mauray S; De Raucourt E; Chaubet F; Maïga-Revel O; Sternberg C; Fischer AM
J Biomater Sci Polym Ed; 1998; 9(4):373-87. PubMed ID: 9586785
[TBL] [Abstract][Full Text] [Related]
59. Laminin promotes formation of cord-like structures by Sertoli cells in vitro.
Hadley MA; Weeks BS; Kleinman HK; Dym M
Dev Biol; 1990 Aug; 140(2):318-27. PubMed ID: 2373256
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of mammary tumor cell adhesion, migration, and invasion by the selective synthetic urokinase inhibitor B428.
Alonso DF; Tejera AM; Farias EF; Bal de Kier Joffe E; Gomez DE
Anticancer Res; 1998; 18(6A):4499-504. PubMed ID: 9891516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
